Absolute Biotech

We’re thrilled to merge with Vector Laboratories! This partnership will enhance our offerings and drive innovation in antibody solutions for the life sciences community. Stay tuned for more updates.

In this recent Nature article, MC-38 murine colon adenocarcinoma cells from Kerafast were used as in vivo mouse tumor models and to create a dendritic cell (DC) vaccine against cancer. Study: nature.com/articles/s4146… MC-38: kerafast.com/productgroup/6…

This 2024 study used @AbsAntibody's anti-TIGIT 1B4 to find that combination therapy targeting TIGIT and Tregs was effective at slowing ovarian cancer, the deadliest gynecological cancer. Full study: tinyurl.com/5efe7vsr

From smallpox inoculations in 1715 to the FDA approving it’s 100th monoclonal antibody in 2021, the advances in science and healthcare made possible by antibodies are truly remarkable. See more milestones in @AbsAntibody's History of Antibodies poster: bit.ly/4jaqyeR

@AbsAntibody, a brand under Absolute Biotech brand, is offering a 10% discount on in silico antibody humanization service until the end of the year. Contact us for a quote today! More details below.

Achieve confidence in your WB results with positive control lysates specific to Everest’s purified goat polyclonal antibody batches. Positive control lysates here: everestbiotech.com/category/posit…

The newest @AbsAntibody blog post discusses recombinant antibody technology and how it is contributing to the fight against antimicrobial resistance. Read the blog: tinyurl.com/ykrbwkn6

Our new article highlights the mechanisms of antibody-mediated cell depletion and how it revolutionizes cancer and autoimmune disease treatment. Read the article here: absoluteantibody.com/general/therap… #AntibodyTherapeutics

Our team, Catherine Bladen PhD and Alex Scott, will be at #PEGSEurope next week in Barcelona, Spain. We invite you to visit us at booth #1310 to learn more about our custom services and explore our extensive antibody reagent catalog.

DON’T MISS OUT: Join @AbsAntibody and Dr. Lucia Lupica Spagnolo tomorrow as we discuss the process of humanizing antibodies from murine and non-murine origins. Register here: bit.ly/3XOOls5

Recent citations of Kerafast cell lines study the effect of dietary probiotics on cancer therapy, how fight or flight mode impacts tumors, and more. Read more: ow.ly/nBMi50Tvuup

Join us Oct. 2 for a live webinar with Dr. Lucia Lupica-Spagnolo as she discusses the Prometheus 2.0™ antibody humanization platform and how it has been optimized to increase expression titers and decrease aggregation of humanized antibodies: bit.ly/3XOOls5

Mpox has been declared a public health emergency. Recombinant engineered antibodies can help develop better vaccines and diagnostics. #Mpox Read more here: absoluteantibody.com/general/2024-m…

Exciting times ahead at ADLM 2024! Visit us at booth #1245 next week to learn more about how our custom sequencing, engineering, and bulk antibody production services. #ADLM2024

Product Development Manager Jane Shatford offers western blotting tips in this new article: ow.ly/Ij4g50SFvob Every Everest antibody includes WB validation data: ow.ly/na3F50SFvoa

From the first smallpox inoculations to the 100th FDA approved monoclonal antibody, check out our full “History of Antibodies” poster for interesting and noteworthy antibody milestones. ow.ly/YBvH50RSskN

We’re at PEGS Boston this week. Visit us at booth #312. Our Chief Operating Officer Dr. Catherine Bladen and VP of Channel Sales Andrew Elston are onsite and ready to discuss the latest in recombinant antibody technology. #PEGSBoston2024 #PEGSBoston

Join us at booth #312 during PEGS Boston next week to discover our comprehensive antibody sequencing, engineering, and recombinant expression services, along with an extensive range of antibody reagents. #PEGSBoston2024 #PEGSBoston

The advancements made to our Prometheus 2.0™ humanization platform have allowed us to expand our services to include humanizing antibodies from non-murine origin species. Watch the short video below for more information: ow.ly/eZrn50RuOze

Our CSO Frans Ramaekers was featured in this new article highlighting advancements in cell cycle research tools. FIX&PERM is one of those tools that open up (literally) cellular interiors for flow cytometry. Full article here: ow.ly/eM6250Rihp1